Symposium on Mucolipin
Function in Disease
Draft Agenda
| |
Monday,
June 2, 2008 |
|
| |
8:00 – 9:00 a.m. |
Registration and Breakfast
|
| |
9:00 – 9:15 a.m. |
Welcome and Opening Remarks
Robert Balaban, Ph.D.
Scientific Director, Division of Intramural Research, National Heart, Lung,
and Blood Institute (NHLBI)
Story C. Landis, Ph.D. (invited)
Director, National Institute of Neurological Disorders and Stroke (NINDS)
Randy Yudenfriend
President, MLIV Foundation |
| |
9:15 – 10:45 a.m. |
Session I: Clinical and Molecular Basis of MLIV
Chair: Susan Slaugenhaupt, Ph.D., Massachusetts General Hospital/Harvard Medical
School
The Clinical Characteristics and Natural History of Mucolipidosis Type IV
Raphael Schiffmann, M.D., Baylor Research Institute
Mucolipin Proteins and Lysosomal Function: Implications for Mucolipidosis Type IV
Gideon Bach, Ph.D., Hadassah Hebrew University Hospital, Israel
Mucolipin Biology and Disease Suppression Hanna Fares, Ph.D., University of Arizona |
| |
10:45 – 11:00 a.m. |
Break |
| |
11:00 a.m. – Noon |
Session I: (continued)
A Murine Model for Mucolipidosis Type IV
Susan Slaugenhaupt, Ph.D., Massachusetts General Hospital/Harvard Medical School
New Potential for a Therapeutic Approach Arising From a Drosophila Model of MLIV
Craig Montell, Ph.D., Johns Hopkins University School of Medicine |
| |
Noon – 1:30 p.m. |
Lunch and Poster Set-Up |
| |
1:30 – 3:00 p.m. |
Session II: Lysosomal Function and Disease
Chair: Steven U. Walkley, Ph.D., D.V.M., Albert Einstein College of Medicine
Fusion, Confusion, or Illusion: A Possible Transport Intermediate Between Late
Endosomes and Lysosomes in Yeast
Thomas Vida, Ph.D., University of Texas Health Science Center
CLC-7 Is the Lysosomal Chloride Transporter Essential for Effective Acidification
Joseph Mindell, M.D., Ph.D., NINDS
Glycoshpingolipid and Cholesterol Involvement in Neurons in MLIV and Related Lysosomal Diseases
Steven U. Walkley, Ph.D., D.V.M., Albert Einstein College of Medicine |
| |
3:00 – 3:15 p.m. |
Break |
| |
3:15 – 4:15 p.m. |
Abnormal Lysosomal Calcium Homeostasis in Mucolipidosis Type IV Cells Can Be Partially Corrected
Following Depletion of Glycosphingolipids With NB-DNJ
Emyr Lloyd-Evans, Ph.D., University of Oxford, United Kingdom
The Lysosomal Cation Channel TRP-ML1 Coordinates a Novel Form of Intercellular Communication Involving the Cell-to-Cell Transfer of Organelles Through Nanotubular Plasma Membrane Bridges
Janice M. LaPlante,
Ph.D., Brigham and Women’s Hospital and Harvard Medical School
The Varitint-Waddler (Va) Deafness Mutation in TRPML3 Generates Constitutive, Inward Rectifying Current and Causes Cellular Degeneration
Jaime García-Añoveros, Ph.D., Northwestern University Feinberg School of Medicine
Investigation of Subunit c of the Mitochondrial ATPase as a Marker for Abnormal Autophagy
Susan Cotman, Ph.D., Massachusetts General Hospital |
| |
4:15 – 6:00 p.m. |
Poster Session |
| |
7:30 – 9:30 p.m. |
Symposium Dinner – Location TBD |
| |
|
|
| |
Tuesday,
June 3, 2008 |
|
| |
8:00 – 9:00 a.m. |
Registration and Breakfast |
| |
9:00 - 10:30 a.m. |
Session III: Localization and Cellular Function of MCOLN1
Chair: Rosa Puertollano, Ph.D., NHLBI
Autophagy: Physiological Functions and Relevance to Disease
Ana Maria Cuervo, M.D., Ph.D., Albert Einstein College of Medicine
Role of Mucolipins in the Regulation of Intracellular Trafficking
Rosa Puertollano, Ph.D., NHLBI
Membrane Traffic and Turnover in Mucolipin-1 Deficient Cells
Ora A. Weisz, Ph.D., University of Pittsburgh School of Medicine
|
| |
10:30 - 10:45 a.m. |
Break |
| |
10:45 a.m. – 12:15 p.m. |
Session III:(continued)
TRPML1 and TRPML3 Block by Transition Metal Kirill Kiselyov, Ph.D., University of Pittsburgh
Effect of Ca2+ and pH on the Cation Channel Activity of Mucolipin-1 (TRP-ML1) and Polycystin-2 (TRP-P2)
Horacio F. Cantiello, D.V.M., Ph.D., Massachusetts General Hospital/Harvard Medical School
and Laboratorio de Canales Iónicos, ININCA - UBA – CONICET, Argentina
Electrophysiological Characterization of the Type IV Mucolipidosis-Associated Protein TRPML1 Haoxing Xu, Ph.D., University of Michigan |
| |
12:15 – 1:15 p.m. |
Lunch |
| |
1:15 – 2:45 p.m. |
Session IV: The Mucolipin Family
Chair: Kirill Kiselyov, Ph.D., University of Pittsburgh
Properties and Functions of TRPML3
Shmuel Muallem, Ph.D., University of Texas Southwestern Medical Center
Activating Mutation in a Mucolipin Transient Receptor Potential Channel Leads to Melanocyte
Loss in Varitint-Waddler Mice
Markus Delling, Ph.D., Harvard Medical School
Funding Opportunities and Research Resources at NINDS
Danilo Tagle, Ph.D., NINDS
|
| |
2:45 – 3:00 p.m. |
Final Remarks and Adjournment |
Last updated: May 5, 2008
|